0001181431-12-036820.txt : 20120615 0001181431-12-036820.hdr.sgml : 20120615 20120615170136 ACCESSION NUMBER: 0001181431-12-036820 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120606 FILED AS OF DATE: 20120615 DATE AS OF CHANGE: 20120615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROE WAYNE I CENTRAL INDEX KEY: 0001216990 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35396 FILM NUMBER: 12910700 MAIL ADDRESS: STREET 1: 5311 ELSMERE AVENUE CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000930553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330511719 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-788-6000 MAIL ADDRESS: STREET 1: 50 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED CORNEAL SYSTEMS INC DATE OF NAME CHANGE: 20000403 4 1 rrd348841.xml FORM 4 X0305 4 2012-06-06 1 0000930553 ISTA PHARMACEUTICALS INC ISTA 0001216990 ROE WAYNE I 50 TECHNOLOGY DRIVE IRVINE CA 92618 1 0 0 0 Common Stock 2012-06-06 4 D 0 38558 9.10 D 0 D Option (right to buy) 3.89 2012-06-06 4 D 0 20000 D 2021-12-05 Common Stock 20000 0 D Option (right to buy) 4.58 2012-06-06 4 D 0 20000 D 2020-12-06 Common Stock 20000 0 D Option (right to buy) 4.72 2012-06-06 4 D 0 20000 D 2019-12-07 Common Stock 20000 0 D Option (right to buy) 0.79 2012-06-06 4 D 0 11100 D 2018-12-10 Common Stock 11100 0 D Option (right to buy) 6.90 2012-06-06 4 D 0 11100 D 2017-10-11 Common Stock 11100 0 D Option (right to buy) 6.08 2012-06-06 4 D 0 16000 D 2016-10-19 Common Stock 16000 0 D Option (right to buy) 5.82 2012-06-06 4 D 0 16000 D 2015-10-13 Common Stock 16000 0 D Option (right to buy) 10.75 2012-06-06 4 D 0 9000 D 2014-10-20 Common Stock 9000 0 D Option (right to buy) 6.96 2012-06-06 4 D 0 16250 D 2013-09-10 Common Stock 16250 0 D Disposed of pursuant to agreement and plan of merger by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger. The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.21 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10). The option which was fully vested on 12/06/11 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.52 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10). The option which was fully vested on 12/07/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.38 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10). The option which was fully vested on 12/10/09 was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.31 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10). The option which was fully vested on 10/11/08 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.20 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10). The option which was fully vested on 10/19/07 was cancelled in the Merger Agreement in exchange for a cash payment equal to $3.02 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10). The option which was fully vested on 10/13/06 was cancelled in the Merger Agreement in exchange for a cash payment equal to $3.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10). The option which was fully vested on 10/20/05 was cancelled in the Merger Agreement. The option which was fully vested on 09/10/04 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.14 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10). /s/ Brian Drazba, Attorney-in-Fact for Wayne I. Roe 2012-06-15